Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Patient Compliance × Anastrozole × Clear all

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 111 Neoplasms 8 Neoplasm Metastasis 6 Carcinoma, Intraductal, Noninfiltrating 6 Breast Carcinoma In Situ 4 Arthralgia 4 Advanced Breast Cancer 4 Osteoporosis 2 Multiple Endocrine Neoplasia Type 1 2 Breast Neoplasms, Male 2 Breast Cancer Metastatic 2 Triple Negative Breast Neoplasms 1 Sexual Dysfunction, Physiological 1 Seizures 1 Recurrence 1 Quality of Life 1 Patient Compliance 1 Pain 1 Ovarian Neoplasms 1 Obesity 1 Lethal Congenital Contracture Syndrome 2 1 Joint Diseases 1 Invasive Breast Cancer 1 Hypogonadism 1 Granulosa Cell Ovarian Cancer 1 Fractures, Bone 1 Erectile Dysfunction 1 Epilepsy 1 Bone Diseases, Metabolic 1 Bone Density 1

Interventions

Patient Navigation 2 Exercise 2 beta-Aminoethyl Isothiourea 1 Self Care 1 Radiation 1 Leuprolide 1 Interviews as Topic 1 Goserelin 1 Clodronic Acid 1 Cisplatin 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00936442 2012-02-14

ARTEMIS

AstraZeneca

Breast Neoplasms, Patient Compliance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡